We are live on ! Find out more
JJ

Johnson & Johnson Portfolio holdings

AUM $799M
1-Year Est. Return 253.51%
This Fund
S&P 500
This Quarter Est. Return
+15.27%
1 Year Est. Return
+253.51%
3 Year Est. Return
+280.64%
5 Year Est. Return
+320.83%
10 Year Est. Return
–
AUM
$878M
AUM Growth
-$262M
Cap. Flow
-$297M
Cap. Flow %
-33.85%
Top 10 Hldgs %
94.53%
Holding
27
New
2
Increased
–
Reduced
–
Closed
3

Top Buys

Rank Stock Value
1
XNCR icon
Xencor
XNCR
+$28.4M
2
NNOX icon
Nano X Imaging
NNOX
+$3.99M

Top Sells

Rank Stock Value
1
ILMN icon
Illumina
ILMN
+$329M
2
NPCE icon
Neuropace
NPCE
+$879K
3
ZY
Zymergen Inc. Common Stock
ZY
+$218K

Sector Composition

Rank Sector Weight
1 Healthcare 99.86%
2 Technology 0.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NPCE icon
26
Neuropace
NPCE
$498M
– –
-55,435
Closed -$879K
ZY
27
DELISTED
Zymergen Inc. Common Stock
ZY
– –
-16,553
Closed -$218K
1
2

Similar funds

HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
ACM
Ashe Capital Management Englewood Cliffs, New Jersey $797M AUM 4.79% 1-Year Est. Return
AGA
Arkos Global Advisors Houston, Texas $797M AUM 15.28% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
UM
Ulysses Management New York $802M AUM 5.35% 1-Year Est. Return
RIM
Redwood Investment Management Scottsdale, Arizona $805M AUM 15.01% 1-Year Est. Return
BCM
Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return
AI
Aperture Investors New York $791M AUM 54.66% 1-Year Est. Return

Johnson & Johnson's Q4 2021 Portfolio in Review

As of Q4 2021, Johnson & Johnson held 27 positions worth $878M, down 23% from $1.14B the previous quarter. Its ten largest holdings account for 95% of the portfolio.

Johnson & Johnson withdrew a net $297M in Q4 2021, closing 3 positions. Its most notable exit was Illumina, an estimated $329M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, down from 100% a quarter earlier, followed by Technology.

Against the trend, Johnson & Johnson opened a new position in Xencor worth $30M.

  • Johnson & Johnson's largest Q4 2021 buy was Xencor: 748,062 shares worth $30M.
  • Johnson & Johnson fully exited Illumina in Q4 2021, selling an estimated $329M.
  • Johnson & Johnson's ten largest holdings make up 95% of its $878M portfolio in Q4 2021.
  • Johnson & Johnson opened 2 new positions and closed 3 in Q4 2021.
  • Johnson & Johnson's portfolio value fell 23% quarter-over-quarter to $878M.

Based on Johnson & Johnson's 13F filing for Q4 2021, filed 14 Feb 2022.